INS and type 2 diabetes mellitus: To note that edaravone delayed the onset of T2D in both genotypes: Interestingly, at day 80 of HFD, when both nontreated wt and LowOXPHOS mice were insulin‐resistant (Fig 7K), GTT values indicated that edaravone‐treated animals were still insulin‐sensitive (Fig 7K) and developed T2D only at day 90–100 of HFD (Fig 7K and L).